about
Dysregulation of miR-15a and miR-214 in human pancreatic cancerAn Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaMicroRNAs are shaping the hematopoietic landscapeMolecular mechanisms of HPV mediated neoplastic progressionKey nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerUtility of microRNAs and siRNAs in cervical carcinogenesisNovel CD20 monoclonal antibodies for lymphoma therapyRituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual MeetingMicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patientsSwitching off malignant mesothelioma: exploiting the hypoxic microenvironmentModulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model.Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyInvolvement of microRNA families in cancer.An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells.Important miRs of pathways in different tumor types.MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix.Gene expression profiles in BCL11B-siRNA treated malignant T cells.Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cellsNovel agents for anti-platelet therapy.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.DNA sequencing methods in human genetics and disease research.Rough sets for in silico identification of differentially expressed miRNAs.miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expressionTargeting MicroRNAs in Cancer Gene Therapy.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization.Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells.The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancerMicroRNAs and human diseases: diagnostic and therapeutic potential.Molecular pathogenesis of intrahepatic cholangiocarcinoma.Monovalent streptavidin that senses oligonucleotides.lincRNA HOTAIR as a novel promoter of cancer progression.The role of microRNAs in oral lichenoid disorders. Systematic review.MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
P2860
Q21198870-64C4476C-3F4B-4324-9BAE-6486DBA6E890Q26784091-59250B34-7B62-430A-AB4B-0CF2D1610FDBQ27027663-49D7B07C-588B-4825-89F5-41D8CE2A8B8BQ28070323-ED5891E8-432D-4771-B66B-6C3218048AA5Q28082679-63B8F51A-2D3F-432D-AB54-D9B00D361CE0Q28083010-887402DA-91A9-4A88-BF3C-EC7EABC5BB91Q28390112-B2746764-F67A-4FC8-A9D9-8C89C0EA8698Q28390181-CA46D2A5-2EC2-41E1-BC2C-D1A3CCBB6BEEQ28545051-9F249015-93F0-43D8-A697-8AE3D82B6FA3Q29248727-215C846A-B5ED-4C4A-9D82-68E504B5E584Q34098359-CCA9A9C3-679C-4963-8230-127BC4E81F82Q34185984-AED96267-145E-4C70-A80F-4CCD65D2B91CQ34256150-16D87EE7-D373-4CF9-A49C-33FBFF128037Q34320326-DD35D531-E2AE-450A-9388-E8414BB800B0Q34523785-3592FCBF-A08C-466C-B6B8-5DBB0DC70AB2Q34566039-A401E61F-E9FC-47AA-A908-86B684482FBFQ34685896-109F0DD2-DA2B-4E97-9C95-1CFD5D670444Q34978603-AE6909EC-692F-4A3B-B0F6-DE44E7156791Q35041552-FF7D6AAD-C200-4480-9F0F-9DE516F6DD09Q35290406-061491AB-AC3F-48D8-B2B8-35650E22F3BCQ35574825-E31DD6E3-8D9E-401A-BF2B-229F8C16301CQ35745018-78BAF63D-D538-4007-956A-D34996675D5FQ35913384-001AF12A-5B63-4653-9BA3-5ECC8CB63B7BQ36312962-AC9E202B-A5ED-4990-A986-7CC9199218A6Q36863089-449D9D94-982C-4682-8241-17C4E497150FQ37159006-8243DE44-8169-47FF-921F-5C7F01ACD460Q37214641-60F86CB6-49EC-4DC9-9ECA-41B218C4BD6BQ37400908-4BA0526C-F6E7-42AA-8C37-A2532CDA0D82Q37628264-389215F5-1F98-4241-B360-3BB09EE495C2Q37681322-98D8FF23-414F-4B30-A2A4-BD985378E588Q37699995-6BE60886-9509-413F-B34C-FFF0B363BE1BQ37700483-B9A2DADE-E926-4979-9D0A-AA72E0488FD3Q37719992-B462C2ED-7AAC-4F8E-A311-692D446E2866Q37997552-86A5B9AE-32F0-47C2-B3AB-60301E46EF74Q38184973-4C6E94A5-18F0-4F46-B96F-D2B5288348FFQ38244965-A5C96219-C709-4873-993F-3587AD09A259Q38316127-667D0BF8-8B9A-41AE-8C06-127FEF3B7FE9Q38348854-5A258346-27A5-4CF5-8D84-0AC0BD58827CQ38624064-5BDEBE46-920F-4339-8FB7-3BF43B52EEEEQ38932242-AFCC3B48-ACBD-4A01-A24E-F2F60AC1702E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The clinical potential of microRNAs
@ast
The clinical potential of microRNAs
@en
The clinical potential of microRNAs
@nl
type
label
The clinical potential of microRNAs
@ast
The clinical potential of microRNAs
@en
The clinical potential of microRNAs
@nl
prefLabel
The clinical potential of microRNAs
@ast
The clinical potential of microRNAs
@en
The clinical potential of microRNAs
@nl
P2093
P2860
P356
P1476
The clinical potential of microRNAs
@en
P2093
Anuradha Budhu
Junfang Ji
Xin W Wang
P2860
P2888
P356
10.1186/1756-8722-3-37
P577
2010-10-06T00:00:00Z
P5875
P6179
1012929331